Global Antacids Market Outlook to 2023; Led by Bayer, GlaxoSmithKline, Johnson & Johnson Services, Novartis and Sanofi - ResearchAndMarkets.com
Tuesday, 01 January 2019 20:06
Jan. 2, 2019 16:41 UTC

Global Antacids Market Outlook to 2023; Led by Bayer, GlaxoSmithKline, Johnson & Johnson Services, Novartis and Sanofi - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)-- The "Global Antacids Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The latest trend gaining momentum in the market is the increasing popularity of e-commerce retailing has been affecting the retailers' efforts on improving the online shopping experience through better online education and targeted marketing.

According to the report, one of the major drivers for this market is the demand for antacids is expected to increase with the rising aging population, thereby driving market growth.

Further, the report states that one of the major factors hindering the growth of this market is the increasing entry of generics into the market.

Key Players

  • Bayer
  • GlaxoSmithKline
  • Johnson & Johnson Services
  • Novartis
  • Sanofi

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY TYPE

PART 07: CUSTOMER LANDSCAPE

  • Market segmentation by type
  • Comparison by type
  • Non-systemic antacids - Market size and forecast 2018-2023
  • Systemic antacids - Market size and forecast 2018-2023
  • Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bayer
  • GlaxoSmithKline
  • Johnson & Johnson Services
  • Novartis
  • Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/frf6hf/global_antacids?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastrointestinal Drugs


Source: Research and Markets




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter